Compare MGNI & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGNI | AMPH |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.2B |
| IPO Year | N/A | 2014 |
| Metric | MGNI | AMPH |
|---|---|---|
| Price | $15.88 | $28.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | $27.67 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 2.0M | 360.6K |
| Earning Date | 02-25-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 219.02 | N/A |
| EPS | 0.38 | ★ 2.27 |
| Revenue | $702,565,000.00 | ★ $723,305,000.00 |
| Revenue This Year | $2.07 | $1.35 |
| Revenue Next Year | $10.93 | $5.10 |
| P/E Ratio | $42.40 | ★ $12.74 |
| Revenue Growth | ★ 6.27 | N/A |
| 52 Week Low | $8.22 | $20.39 |
| 52 Week High | $26.65 | $39.01 |
| Indicator | MGNI | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 45.28 | 64.25 |
| Support Level | $15.76 | $27.31 |
| Resistance Level | $17.41 | $29.52 |
| Average True Range (ATR) | 0.63 | 0.91 |
| MACD | -0.08 | 0.23 |
| Stochastic Oscillator | 8.81 | 86.00 |
Magnite is a supply-side advertising platform that provides technology and yield management solutions to content publishers, enabling them to monetize their digital advertising inventory. Magnite receives a percentage of all advertising inventory that it sells. 43% of Magnite's revenue is derived from connected television, or CTV, streaming platforms, 40% from mobile applications, and the remainder from general websites. Beyond the typical monetization responsibilities inherent to an SSP, Magnite also provides upstream advertising servers to CTV publishers, allowing them to have granular control over direct-sold, programmatic guaranteed, and open-auction logic. Magnite competes with other independent SSPs, supply path optimization solutions, and closed ecosystems like Meta.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.